Navigation Links
Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
Date:12/11/2008

available at www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements about the results of the company's Vaxfectin(R)-formulated H5N1 influenza DNA vaccine Phase 1 clinical trial and the results of nonclinical mouse studies of Vaxfectin(R)-formulated influenza vaccines produced by the company's RapidResponse(TM) manufacturing system. Risks and uncertainties include whether Vical or others will continue development of the H5N1 pandemic influenza vaccines or the RapidResponse(TM) DNA vaccine platform; whether H5N1 influenza DNA vaccine Phase 1 clinical trial results will be confirmed in larger studies; whether nonclinical results from mouse studies will advance to human clinical testing, and if so, whether such testing will yield similar results; whether the company will receive all of the NIH grant funding; whether DNA vaccines against H5N1 influenza or any other targets will be successfully developed and commercialized; whether Vical or its collaborative partners will seek or gain approval to market the influenza vaccine or any other product candidates; whether Vical or its collaborative partners will succeed in marketing any product candidates; whether Vical or others will secure funding to advance the pandemic influenza DNA vaccine program; whether any product candidates will be shown to be safe and efficacious in clinical trials; the timing of clinical trials; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update th
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
2. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
3. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
4. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
5. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
6. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
7. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
9. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
10. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
11. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Biotechnology Inc. ("Sony") today announced the launch of the new ... Sony will also be exhibiting its newly rebranded reagent portfolio. ... EC800 flow cytometer, and new SP6800 Spectral Analyzer will be ... held at the San Diego Convention ... May 20 - 22.  The 8-well strip ...
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will report ... Ken Berger , CEO, and Ed Borkowski , ... live via telephone. To participate in the conference call ... To participate in the conference call outside the U.S. and ... conference ID is 72195398. Participants should dial in 10 minutes ...
(Date:5/17/2013)... MONTVALE, N.J. , May 17, 2013 /PRNewswire/ ... imaging, and Hitachi-Aloka Medical, a global leader in ... the two global companies to enable further innovation ... For years, the Hitachi-Aloka ultrasound systems and PENTAX ... world,s most trusted families of EUS systems. This ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3
(Date:5/18/2013)... Bay, CA (PRWEB) May 18, 2013 ... , has recently completed a stylish renovation that features ... advanced specialties. , From the ground up, this ... improved with fresh flooring, soothing colors and comfortable spa ... been installed, including an Apilus epilator machine. The ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental ... knowledge of the root causes of sleep apnea to provide ... Better Sleep Month, Dr. Tracey points out estimates revealing that ... and sleep apnea is one of the most common of ... stop breathing at different times while sleeping. When this happens, ...
(Date:5/18/2013)... 2013 The topics that will be covered ... scrum roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... attending them. , These trainings are suitable for business analysts, ... for those who will be a part of the Scrum ... to explore Agile and Scrum, but are unsure of what ...
(Date:5/18/2013)... May 18, 2013 Kimono condoms ... America’s favorite condom store recently announced. Condomania recently ... store's large selection of condoms from all over the ... it easy to try different condom styles from one ... Featuring Kimono’s classic comfortable shape and secure, the new ...
(Date:5/18/2013)... 18, 2013 Medical device company, FlexLeg, LLC, ... much anticipated mobility aid with its namesake, the FlexLeg. ... crutch alternative that injured individuals can use to ... example, can remain active and walk during a typical 6-8 ... reservation system to ensure those who need the device most ...
Breaking Medicine News(10 mins):Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2Health News:FlexLeg Begins Offering New Mobility Aid 2
... ... Hormonal health is a struggle for women of all ages. Despite the ... something non-synthetic for symptomatic relief of menstrual and menopausal woes. Garden of ... is providing women of all ages a natural way to balance hormones ...
... Laurence Barsh, DMD spoke at ... 2009 on the subject of educating the public about dentistry,s role in the management of snoring ... New York, NY ... Sleep Medicine in Seattle on June 5, 2009 on the subject of educating the public about ...
... The following statement was issued Wednesday, June 10, ... M. Pavlinac, following a press conference by U.S. Sen. ... menu labeling to be included in the Senate,s Committee ... reform legislation. , , "The American Dietetic Association ...
... Allscripts announced today that its 3.50 percent Convertible ... at the option of the holders of the Debentures ... August 31, 2009. Any determinations regarding the convertibility ... in accordance with the terms of the indenture under ...
... June 10 IPC The Hospitalist Company, Inc. (Nasdaq: ... that management is scheduled to present at the Jefferies 3rd Annual ... City. Adam Singer, M.D., Chairman and CEO, and Jeff Taylor, ... presentation will take place at 3:15 P.M. Eastern time on Thursday, ...
... /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) ... appointed Vice President Finance & Administration and Chief Financial ... experience in several industries. , "Following the Annual General ... to recognize Livleen for her outstanding financial leadership in ...
Cached Medicine News:Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™ 2Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™ 3Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™ 4Health News:Founder of Snoring Isn't Sexy, LLC Addresses Annual Meeting of the American Academy of Dental Sleep Medicine 2Health News:Statement by American Dietetic Association Supporting Scientifically Valid, Informative Restaurant Labeling as Part of Health Reform 2Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 2Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 3Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 4Health News:IPC The Hospitalist Company, Inc. to Present at Jefferies 3rd Annual Healthcare Conference 2Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 2Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 3Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 4
... lenses are manufactured using the ... Perspex CQ UV PMMA material ... and single piece lenses. Unioptic ... both nonphaco and phaco styles. ...
... Posterior Chamber Lenses: The Bausch & Lomb ... be used for primary implantation for the visual ... age or older where a cataractous lens has ... are intended to be placed in the ciliary ...
Single piece Anterior Chamber PMMA lens, AC depth: 4.9....
Liberty Single Piece PMMA Lens with UV Absorber....
Medicine Products: